These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23497288)

  • 1. miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor.
    Iida K; Fukushi J; Matsumoto Y; Oda Y; Takahashi Y; Fujiwara T; Fujiwara-Okada Y; Hatano M; Nabashima A; Kamura S; Iwamoto Y
    Cancer Cell Int; 2013 Mar; 13(1):21. PubMed ID: 23497288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.
    Robin TP; Smith A; McKinsey E; Reaves L; Jedlicka P; Ford HL
    Mol Cancer Res; 2012 Aug; 10(8):1098-108. PubMed ID: 22723308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1.
    Hu G; Zhao X; Wang J; Lv L; Wang C; Feng L; Shen L; Ren W
    Oncol Lett; 2018 Feb; 15(2):1621-1629. PubMed ID: 29434858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells.
    Zhou X; Chen J; Xiao Q; Wang T; Yu Y; Li B; Shao G; Li Y; Zhang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Down-Regulation of MiR-125b Reverses Drug Resistance of Doxorubicin-Resistant Leukemia Cells].
    Deng YM; Luo AL; Li GF; Cai MS; Xu L; Yan MX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1610-1615. PubMed ID: 30501692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
    Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
    Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
    Zhou M; Liu Z; Zhao Y; Ding Y; Liu H; Xi Y; Xiong W; Li G; Lu J; Fodstad O; Riker AI; Tan M
    J Biol Chem; 2010 Jul; 285(28):21496-507. PubMed ID: 20460378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.
    McKinsey EL; Parrish JK; Irwin AE; Niemeyer BF; Kern HB; Birks DK; Jedlicka P
    Oncogene; 2011 Dec; 30(49):4910-20. PubMed ID: 21643012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.
    Kong F; Sun C; Wang Z; Han L; Weng D; Lu Y; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):543. PubMed ID: 21823019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
    Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
    Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.
    Yuan WX; Gui YX; Na WN; Chao J; Yang X
    Oncol Lett; 2016 Jan; 11(1):423-432. PubMed ID: 26870228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
    Ragheb MA; Soliman MH; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
    Anticancer Agents Med Chem; 2021; 21(2):237-245. PubMed ID: 32357822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
    Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
    Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
    Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
    Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
    Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.
    Roberto GM; Vieira GM; Delsin LEA; Silva MO; Hakime RG; Engel EE; Scrideli CA; Tone LG; Brassesco MS
    Cancer Genet; 2019 Jan; 230():21-27. PubMed ID: 30470587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.